DVL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.291200E-01
Normal-vs-Stage2
9.505000E-01
Normal-vs-Stage3
2.851800E-01
Normal-vs-Stage4
4.712800E-01
Stage1-vs-Stage2
8.699800E-01
Stage1-vs-Stage3
1.835590E-01
Stage1-vs-Stage4
3.201600E-01
Stage2-vs-Stage3
1.069360E-01
Stage2-vs-Stage4
3.224200E-01
Stage3-vs-Stage4
1.479240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.399400E-01
Normal-vs-AfricanAmerican
9.606200E-01
Normal-vs-Asian
7.270400E-01
Caucasian-vs-AfricanAmerican
8.509000E-01
Caucasian-vs-Asian
6.535800E-01
AfricanAmerican-vs-Asian
8.544400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.928200E-01
Normal-vs-Female
9.773800E-01
Male-vs-Female
9.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.175800E-01
Normal-vs-Age(41-60Yrs)
5.098800E-01
Normal-vs-Age(61-80Yrs)
7.926000E-01
Normal-vs-Age(81-100Yrs)
5.826600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.900400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.308800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.621800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.679000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.919870E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.016200E-01
Normal-vs-Daily Drinker
5.262800E-01
Normal-vs-Weekly Drinker
7.223000E-01
Normal-vs-Occasional Drinker
8.517400E-01
Normal-vs-Social Drinker
3.913600E-01
Non Drinker-vs-Daily Drinker
8.406400E-01
Non Drinker-vs-Weekly Drinker
1.098230E-01
Non Drinker-vs-Occasional Drinker
1.682560E-01
Non Drinker-vs-Social Drinker
1.339500E-02
Daily Drinker-vs-Weekly Drinker
9.481900E-02
Daily Drinker-vs-Occasional Drinker
1.360430E-01
Daily Drinker-vs-Social Drinker
1.089750E-02
Weekly Drinker-vs-Occasional Drinker
7.163800E-01
Weekly Drinker-vs-Social Drinker
5.583600E-01
Occasional Drinker-vs-Social Drinker
2.780200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.576400E-01
Normal-vs-Grade 2
8.300400E-03
Normal-vs-Grade 3
2.223700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.416700E-03
Grade 1-vs-Grade 3
9.682200E-03
Grade 1-vs-Grade 4
1.576400E-01
Grade 2-vs-Grade 3
6.042800E-01
Grade 2-vs-Grade 4
8.300400E-03
Grade 3-vs-Grade 4
2.223700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.628800E-01
Normal-vs-NonDiabetic
9.490000E-01
Diabetic-vs-NonDiabetic
1.215150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.364000E-01
Normal-vs-NoPancreatitis
8.873800E-01
Pancreatitis-vs-NoPancreatitis
9.612500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.800000E-01
Normal-vs-N1
9.500000E-01
N0-vs-N1
2.493400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.887800E-01
Normal-vs-TP53-NonMutant
1.726410E-01
TP53-Mutant-vs-TP53-NonMutant
5.507700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
